ETFs positioned on Haisco Pharmaceutical Group Co., Ltd.

Logo Haisco Pharmaceutical Group Co., Ltd.
Haisco Pharmaceutical Group Co Ltd is a China-based company principally engaged in the research, development, manufacture and sale of new drugs and high-end medical instrument. The Company mainly provides sales of finished drugs and raw materials, patent technology services, new drug research and development, marketing services and others. The Company’s main products are categorized into small volume injections, big volume injections, freeze-dried powder injections and others, which include polyene phosphatidylcholine injections, lipid solubility vitamins injection series, doradiazine methanesulfonate injections, nalmefene hydrochloride injections, fluprofen tromethamine tablets and cefoperazone sodium tazobactam sodium for injections, among others. The Company distributes its products in the domestic market.
Employees
5,597
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
69.33CNY
Average target price
99.08CNY
Spread / Average Target
+42.91%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002653 Stock
  4. ETFs Haisco Pharmaceutical Group Co., Ltd.